CTRI/2018/04/012963
Completed
未知
Breast cancer classification according to immunohistochemistry markers and its relationship with clinicopathological features, treatment outcome and survival analysis.
Government funded Institution0 sites286 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: null- Known cases of biopsy proven breast cancer in females.
- Sponsor
- Government funded Institution
- Enrollment
- 286
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Unilateral, biopsy proven invasive ductal carcinoma(IDC) breast with baseline normal hematological, renal and hepatic profile and baseline normal cardiac and pulmonary function status. Any T, any N, M0 stage.
Exclusion Criteria
- •Any evidence of distant metastasis at presentation, pregnant or lactating patients, previous history of any breast malignancy, presence of serious comorbidities or deranged hematological or biochemical parameters.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Studying patients presenting to GMCH with Breast cancer and classifying them into molecular subgroupsHealth Condition 1: C509- Malignant neoplasm of breast of unspecified siteCTRI/2023/11/060202Government Medical College and Hospital, Sector 32 Chandigarh
Recruiting
Not Applicable
Tumor differentiation in breast carcinomas with a novel physical methodC50Malignant neoplasm of breastDRKS00012767Department für Frauengesundheit150
Recruiting
Not Applicable
Tumor response assessment in breast cancer patients receiving neoadjuvant systemic therapy using optical mammography: the Softscan Studybreast cancermammacarcinoma10006291NL-OMON36040eids Universitair Medisch Centrum42
Recruiting
Not Applicable
Immunohistochemical analysis of malignancy grade in patients with intrahepatic cholangiocarcinoma.Intrahepatic cholangiocarcinomaJPRN-UMIN000009210Department of Gastroenterological Surgery, Yokohama City University Graduated school of Medicine100
Recruiting
Not Applicable
Hereditary breast cancer and the clinical significance of variants in the BRCA1 and BRCA2 genes.hereditary breast cancermamma carcinoma1008362410006291NL-OMON37491eids Universitair Medisch Centrum270